Literature DB >> 22155686

Allopregnanolone prevents memory impairment: effect on mRNA expression and enzymatic activity of hippocampal 3-α hydroxysteroid oxide-reductase.

Carla Escudero1, Sebastián Casas, Fernando Giuliani, Vanesa Bazzocchini, Sebastián García, Roberto Yunes, Ricardo Cabrera.   

Abstract

In this work we investigated how the neurosteroid allopregnanolone can modulate learning and memory processes. For this purpose, we used ovariectomized (OVX) rats subcutaneously injected with oestradiol benzoate (E) alone or E and progesterone (P). Then, rats were injected in dorsal hippocampus with allopregnanolone or vehicle. Animals were tested in inhibitory avoidance task (IA task). After behavioural test hippocampal mRNA expression and enzymatic activity of 3α-HOR, the enzyme responsible of allopregnanolone synthesis, were analysed. In IA task OVX-EP rats spent less time on platform, compared to those OVX or OVX-E. Regression analyses revealed that there was a significant negative relationship between E-P infusion and performance in this task. Pre-training allopregnanolone administration to OVX-EP rats increased the time spent on the platform. Interestingly, when enzymatic activity of 3α-HOR was tested, OVX-EP rats showed a significant decrease in the enzymatic activity, compared with OVX and OVX-E rats. In addition, OVX-EP group showed a significant increase in the enzymatic activity after intrahippocampal infusion of allopregnanolone. On the other hand, when mRNA expression of 3α-HOR was analysed no differences were observed when the hippocampal allopregnanolone injection was done. These results suggest that E and P have amnesic effects on female rats, being reversed by allopregnanolone through its modulation on hippocampal 3α-HOR activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155686     DOI: 10.1016/j.brainresbull.2011.11.019

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  Allopregnanolone reversion of estrogen and progesterone memory impairment: interplay with serotonin release.

Authors:  C Escudero; F Giuliani; M Mulle Bernedo; Roberto Yunes; R Cabrera
Journal:  J Neural Transm (Vienna)       Date:  2019-08-03       Impact factor: 3.575

Review 2.  Neurosteroids Involvement in the Epigenetic Control of Memory Formation and Storage.

Authors:  Alessandra Colciago; Valerio Magnaghi
Journal:  Neural Plast       Date:  2016-12-20       Impact factor: 3.599

3.  Progesterone Exerts a Neuromodulatory Effect on Turning Behavior of Hemiparkinsonian Male Rats: Expression of 3 α -Hydroxysteroid Oxidoreductase and Allopregnanolone as Suggestive of GABAA Receptors Involvement.

Authors:  Roberto Yunes; Sebastián Casas; Eliana Gaglio; Ricardo Cabrera
Journal:  Parkinsons Dis       Date:  2015-03-31

4.  Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.

Authors:  Hong-Qiang Qiu; Ying Xu; Gui-Lin Jin; Jian Yang; Ming Liu; Su-Ping Li; Chang-Xi Yu
Journal:  Mol Pain       Date:  2015-08-09       Impact factor: 3.395

5.  Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats.

Authors:  Sha Liu; Honghai Wu; Gai Xue; Xin Ma; Jie Wu; Yabin Qin; Yanning Hou
Journal:  Neural Regen Res       Date:  2013-10-25       Impact factor: 5.135

Review 6.  Understanding the role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach.

Authors:  D Adhya; E Annuario; M A Lancaster; J Price; S Baron-Cohen; D P Srivastava
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

7.  Allopregnanolone alters follicular and luteal dynamics during the estrous cycle.

Authors:  Joana Antonela Asensio; Antonella Rosario Ramona Cáceres; Laura Tatiana Pelegrina; María de Los Ángeles Sanhueza; Leopoldina Scotti; Fernanda Parborell; Myriam Raquel Laconi
Journal:  Reprod Biol Endocrinol       Date:  2018-04-10       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.